search
for
 About Bioline  All Journals  Testimonials  Membership  News


Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 7, No. 2, 1997
Bioline Code: au97011
Full paper language: English
Document type: Research Article
Document available free of charge

Australasian Biotechnology (backfiles), Vol. 7, No. 2, 1997

 en Editorial, News, Bio shares

Abstract

Australasian Biotechnology, 
Volume 7 Number 2, March/April 1997, pp.66-86 & 108-123  

Editorial, News, Bio shares

Code Number: AU97011
Size of Files:
    Text: 117.1K
    Graphics: No associated graphics files

FROM THE PRESIDENT 

Agricultural Biotechnology Needs Investment Not Additional Regulation

I was recently browsing on the world wide web and came across a list of
`Agricultural Biotechnology Products Expected on the Market Within Six
Years'. There were over twenty-five different types of product ranging from
late ripening fruits (bananas, strawberries, raspberries, tomatoes),
vegetables with enhanced properties (such as the potato with higher density
starch that when deep fried takes up less fat; and peppers that are sweeter
firmer and tastier) and of course a range of disease resistant or herbicide
resistant crop plants. There was even a tree that had modified lignin,
facilitating its easy removal from cellulose and therefore requiring less
energy and bleaching resulting in benefits to both the paper processor and
the environment.

NEWS 

$44m in R&D Start large grants announced 

The Industry Research and Development Board announced on 19th March
successful recipients of grants under the first round of the R&D Start
program - large grants element. Sixteen projects have been offered a total
of $44 million. 

Biota Announces Zanamivir Will Enter Phase III Clinical Trials in May 1997 

Biota Holdings Limited (Australian Stock Exchange: BTA) announced on
24th February that Glaxo Wellcome plc, the Company's development partner,
has informed management that Phase III clinical trials of zanamivir, or
GG167, for the treatment of influenza, planned to start in 1997, will begin
in Australia in May. This Southern Hemisphere trial will be a part of a
comprehensive world-wide Phase III programme which will also include two
separate pivotal proof of efficacy studies to be initiated in the Northern
Hemisphere from October of this year. 

Dolly - The Science Behind the Sensation 
Moratorium Reaction 
Responses in the US 

Australia Urged to Back Winners 

Fish Studies Reveal the Good Oil 

Collaborators Sought for the Roslin and Moredun 

Stress Proteins and Human Ageing 


Human Hemoglobin-producing Tobacco 

The Biotechnology Industry Organization (BIO) and SciQuest(sm) to form
Internet Partnership 

Bioethical Aspects of Biotechnology in the Agrofood Sector -
Developing Countries 

MORE DOLLY NEWS 
Dolly Cloning Raises Ire of Anti Biotech Lobby 
Nuclear Transfer in Humans 

Position Statement on Cloning by the Council for Responsible Genetics

New Pharmaceutical Policies 

LATE NEWS 

New Company - Enzyme Solutions Pty Ltd 

COMPANY NEWS

Peptech awarded Major Grant for Drug Development 

New $3.5 Million Microbiology Plant Planned for Brisbane 

"START" Program Funding for Biotech Australia 

Rancoo Changes its Name and Appoints a New CEO 

Profile: Dr Paul Tolstoshev, BresaGen 
Sheep Cloning an "Important Step" in Transplant Research - Geneticist

AGEN Reports Break-even Result 

New Drug Blows Away Cold and Flu Symptoms 

BIO SHARES
Covering Australian Biotechnology Stocks - compiled by M.J. Playne

Introducing a New Corporate Member Gist-brocades in Australia
The People and Gist-brocades 
The Products 
Cultures 
Ingredients 
Preservation 
Tests 
Quality Assurance 

ASIAN NEWS

Asian Bioscience Improving Rapidly but Still has a Long Way to Go

Foot and mouth disease has finally hit Taiwan after 63 years of absence.

REGULATORY NEWS

USA EPA Issues New Notification and Screening Requirements for Microbial 
Biotech Products 

Canadian Biotech Regulations 

PATENT NEWS

Contributed by Dr. Vivien Santer

Extension of Patent Term Re-Instated 
Discussion Paper on Patentability Standards 
Official Fees in the European Patent Office being Reduced 
Philippines to Adopt First to File System 
Supreme Court Upholds Doctrine of Equivalents in the United States

General Patent News 

ABA NEWS

Biotechnology Industry Organization (BIO) 
AusBiotech Alliance 
Submissions to Government Reviews 
Gene Technology Authority 
Regional Meetings 

BIO Meeting 

News from New Zealand
by Ian Maddox, President, New Zealand Biotechnology Association

Annual General Meeting 

PRODUCT NEWS

Pall and Gelman Sciences Complete Merger 

Crown Scientific 
The Eppendorf Model 5171 Micromanipulator 
The Cell Becomes a Test Tube 
Eppendorf Release the Titerman for Low Volume Ranges of 0.5 uL to 10 uL 

Trace Scientific
Assayed Cardiac Enzyme Control 

Mettler Toledo

ATCC
Express-CheckTM Kit 
ATCC Introduces VitaCellTM Cell Culture Media & Serum 

Scientific Associates 
Stedim Flexboy and Biopharm Sterile Carboys 

Copyright 1997 Australian Biotechnology Association Ltd.

 

Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2025, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil